Michael Link
Publications
- Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma. JAMA. 2012; (24): 2609-16
- The impact of drug shortages on children with cancer--the example of mechlorethamine. N Engl J Med. 2012; (26): 2461-3
- Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy. J Clin Oncol. 2010; (7): 1232-9
- ALK+ anaplastic large cell lymphoma exhibits phosphatidylinositol-3 kinase/Akt activity with retained but inactivated PTEN--a report from the Children's Oncology Group. Pediatr Blood Cancer. 2012; (3): 440-7
- Adolescent and young adult oncology. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2012; (9): 1112-50
- Chemotherapy drug shortages in the United States: genesis and potential solutions. J Clin Oncol. 2012; (7): 692-4
- Complete ocular paresis in a child with posterior fossa syndrome. Pediatr Neurosurg. 2012; (1): 51-4
- Extremely low-frequency magnetic fields and survival from childhood acute lymphoblastic leukemia: an international follow-up study. Blood Cancer J. 2012: e98
- The impact of the privacy rule on cancer research: variations in attitudes and application of regulatory standards. J Clin Oncol. 2009; (24): 4014-20
- Nodular lymphocyte-predominant Hodgkin lymphoma presenting as fulminant hepatic failure in a pediatric patient: a case report with pathologic, immunophenotypic, and molecular findings. Appl Immunohistochem Mol Morphol. 2008; (2): 196-201
- Non-anaplastic peripheral t-cell lymphoma in childhood and adolescence: a Children's Oncology Group study. Pediatr Blood Cancer. 2008; (1): 29-33
- Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. J Clin Oncol. 2008; (4): 633-8
- Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease. J Clin Oncol. 2007; (3): 332-7
- Magnetic field exposure and prognostic factors in childhood leukemia. Bioelectromagnetics. 2007; (1): 69-71
- Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group. Blood. 2007; (1): 46-51
- Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group. Pediatr Blood Cancer. 2007; (7): 894-900
- Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology Group. J Clin Oncol. 2006; (1): 152-9
- Magnetic field exposure and long-term survival among children with leukaemia. Br J Cancer. 2006; (1): 161-4
- Review of tonsillar lymphoma in pediatric patients from the pediatric oncology group: what can be learned about some indications for microscopic examination? Pediatr Dev Pathol. 2005 Sep-Oct; (5): 533-40
- Epstein-Barr virus-associated peripheral T-cell lymphoma and hemophagocytic syndrome arising after liver transplantation: case report and review of the literature. Pediatr Blood Cancer. 2005; (3): 270-6
- Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol. 2005; (9): 2004-11
- Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children's oncology group. Clin Cancer Res. 2004; (18 Pt 1): 6072-9
- High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma. Cancer. 2004; (8): 1724-33
- High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric Hodgkin's disease: results and prognostic indices. J Clin Oncol. 2004; (22): 4532-40
- National Institutes of Health State-of-the-Science Conference Statement: Symptom management in cancer: pain, depression, and fatigue, July 15-17, 2002. J Natl Cancer Inst Monogr. 2004; (32): 9-16
- Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease. J Clin Oncol. 2004; (22): 4541-50
- Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study. J Clin Oncol. 2004; (14): 2873-6
- Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med. 2003; (8): 694-701
- National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15-17, 2002. J Natl Cancer Inst. 2003; (15): 1110-7
- Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol. 2003; (8): 1574-80
- Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol. 2003; (1): 78-84
- Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy. J Clin Oncol. 2003; (10): 2026-33
- National action plan for childhood cancer: report of the national summit meetings on childhood cancer. CA Cancer J Clin. 2002 Nov-Dec; (6): 377-9
- Assessment of lymphadenopathy in children. Pediatr Clin North Am. 2002; (5): 1009-25
- Bone marrow stroma-supported culture of T-lineage acute lymphoblastic leukemic cells predicts treatment outcome in children: a Pediatric Oncology Group study. Leukemia. 2002; (6): 1121-6
- Children from ethnic minorities have benefited equally as other children from contemporary therapy for rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol. 2002; (22): 4428-33
- Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in children with solid tumors: a pediatric oncology group study. Clin Cancer Res. 2002; (2): 413-8
- Minimax two-stage-designs with applications to tissue banking case-control studies. Stat Med. 2002; (17): 2479-93
- Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial. J Clin Oncol. 2002; (2): 426-33
- Treatment of unfavorable childhood Hodgkin's disease with VEPA and low-dose, involved-field radiation. J Clin Oncol. 2002; (14): 3088-94
- VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial. J Clin Oncol. 2002; (14): 3081-7
- Thyroid carcinoma after successful treatment of osteosarcoma: a report of three patients. J Pediatr Hematol Oncol. 2001 Jun-Jul; (5): 312-5
- Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group Trial. J Pediatr Hematol Oncol. 2001 Aug-Sep; (6): 340-8
- Attitudes and practices among pediatric oncologists regarding end-of-life care: results of the 1998 American Society of Clinical Oncology survey. J Clin Oncol. 2001; (1): 205-12
- Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma? Semin Pediatr Surg. 2001; (3): 146-52
- Efficacy of ifosfamide and doxorubicin given as a phase II "window" in children with newly diagnosed metastatic rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group. Med Pediatr Oncol. 2001; (5): 442-8
- What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract? Cancer. 2001; (12): 2454-68
- Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children's oncology group. J Clin Oncol. 2001; (20): 4058-64
- Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol. 2000; (12): 2427-34
- Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons. Ann Oncol. 2000: 35-8
- Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report. Leukemia. 2000; (3): 369-73
- New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases. Blood. 2000; (7): 2543-9
- Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation and FAB L3 morphology associated with a B-precursor immunophenotype: the Pediatric Oncology Group experience. Leukemia. 1999; (1): 135-41
- Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation. J Clin Oncol. 1999; (1): 191-6
- Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. Leukemia. 1999; (3): 335-42
- Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study. Leukemia. 1999; (11): 1696-707
- Treatment of localized primary non-Hodgkin's lymphoma of bone in children: a Pediatric Oncology Group study. J Clin Oncol. 1999; (2): 456-9
- A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group. Int J Radiat Oncol Biol Phys. 1998; (1): 125-35
- E2A-PBX1 chimeric transcript status at end of consolidation is not predictive of treatment outcome in childhood acute lymphoblastic leukemias with a t(1;19)(q23;p13): a Pediatric Oncology Group study. Blood. 1998; (3): 1021-8
- Randomized trial of r-metHu granulocyte colony-stimulating factor in an intensive treatment for T-cell leukemia and advanced-stage lymphoblastic lymphoma of childhood: a Pediatric Oncology Group pilot study. J Clin Oncol. 1998; (2): 522-6
- Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study. J Clin Oncol. 1998; (11): 3641-8
- A feasibility, toxicity, and early response study of etoposide, ifosfamide, and vincristine for the treatment of children with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS) IV pilot study. J Pediatr Hematol Oncol. 1997 Mar-Apr; (2): 124-9
- Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemia. J Clin Oncol. 1997; (3): 1158-62
- Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group study. Blood. 1997; (4): 1143-6
- Fractionated cylophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology Group. Med Pediatr Oncol. 1997; (6): 526-33
- Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia. Cancer Res. 1997; (5): 832-6
- Lack of ETV6 (TEL) gene rearrangements or p16INK4A/p15INK4B homozygous gene deletions in infant acute lymphoblastic leukemia. Leukemia. 1997; (7): 979-83
- Treatment of children and young adults with early-stage non-Hodgkin's lymphoma. N Engl J Med. 1997; (18): 1259-66
- Use of an anti-ALK antibody in the characterization of anaplastic large-cell lymphoma of childhood. Ann Oncol. 1997: 37-42
- High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis. Blood. 1996; (3): 1155-61
- Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study. J Clin Oncol. 1996; (4): 1252-61
- NCCN pediatric osteosarcoma practice guidelines. The National Comprehensive Cancer Network. Oncology (Williston Park). 1996; (12): 1799-806, 1812
- Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol. 1996; (1): 18-24
- B-cell lineage confers a favorable outcome among children and adolescents with large-cell lymphoma: a Pediatric Oncology Group study. J Clin Oncol. 1995; (8): 2023-32
- Safety and efficacy of l-leucovorin rescue following high-dose methotrexate for osteosarcoma. Med Pediatr Oncol. 1995; (6): 362-7
- Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells. Exp Hematol. 1995; (11): 1160-6
- Treatment of osteosarcoma with ifosfamide: comparison of response in pediatric patients with recurrent disease versus patients previously untreated: a Pediatric Oncology Group study. Med Pediatr Oncol. 1995; (2): 87-92
- ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience. J Clin Oncol. 1994; (10): 2160-6
- Ewing's sarcoma--routine diagnostic utilization of MIC2 analysis: a Pediatric Oncology Group/Children's Cancer Group Intergroup Study. Hum Pathol. 1994; (3): 304-7
- Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood. 1994; (2): 570-3
- Hodgkin's disease in the very young. Int J Radiat Oncol Biol Phys. 1994; (1): 77-83
- Hypnosis in the prevention of chemotherapy-related nausea and vomiting in children: a prospective study. J Dev Behav Pediatr. 1994; (4): 258-64
- MIC2 analysis in pediatric lymphomas and leukemias. Hum Pathol. 1994; (4): 396-9
- Presenting characteristics of trisomy 8 as the primary cytogenetic abnormality associated with childhood acute lymphoblastic leukemia. A Pediatric Oncology Group (POG) Study (8600/8493). Cancer Genet Cytogenet. 1994; (1): 6-10
- Secondary breast cancer in patients presenting with osteosarcoma: possible involvement of germline p53 mutations. Med Pediatr Oncol. 1994; (4): 354-8
- Simultaneous expression of RBTN-2 and BCR-ABL oncogenes in a T-ALL with a t(11;14)(p13;q11) and a late-appearing Philadelphia chromosome. Leukemia. 1994; (7): 1124-30
- A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias. Blood. 1993; (5): 1124-31
- Acute hypersensitivity reactions to etoposide in a VEPA regimen for Hodgkin's disease. J Clin Oncol. 1993; (6): 1080-4
- Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study. Blood. 1993; (8): 2110-7
- Detection of the (11;22)(q24;q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction. Am J Pathol. 1993; (5): 1294-300
- HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities. Blood. 1993; (12): 3197-203
- Immunocytochemical study of 12E7 in small round-cell tumours of childhood: an assessment of its sensitivity and specificity. Histopathology. 1993; (6): 557-61
- Laboratory-clinical interface. Cancer. 1993; (10 Suppl): 3219-21
- Langerhans' cell histiocytosis presenting with the superior vena cava syndrome: a case report. Med Pediatr Oncol. 1993; (6): 456-9
- Osteosarcoma in adolescents and young adults: new developments and controversies. Commentary on the use of presurgical chemotherapy. Cancer Treat Res. 1993: 383-5
- The multi-institutional osteosarcoma study: an update. Cancer Treat Res. 1993: 261-7
- A study of toxicity and comparative therapeutic efficacy of vindesine-prednisone vs. vincristine-prednisone in children with acute lymphoblastic leukemia in relapse. A Pediatric Oncology Group study. Invest New Drugs. 1992; (3): 231-4
- Acute lymphoblastic leukemia occurring as a second malignant neoplasm in childhood: report of three cases and review of the literature. J Clin Oncol. 1992; (1): 156-63
- Childhood malignant non-Hodgkin lymphomas of uncommon histology. Leukemia. 1992; (8): 761-5
- Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group. Leukemia. 1992: 162-6
- Intensive sequential chemotherapy for children with acute myelogenous leukemia: VAPA, 80-035, and HI-C-Daze. Leukemia. 1992: 48-51
- Isochromosomes in childhood acute lymphoblastic leukemia: a collaborative study of 83 cases. Blood. 1992; (9): 2384-91
- Morphologic, immunologic and cytogenetic studies in children with acute lymphoblastic leukemia at diagnosis and relapse: a Pediatric Oncology Group study. Leukemia. 1992; (5): 357-62
- Osteosarcoma: good news despite crude tools. J Clin Oncol. 1992; (1): 1-2
- t(2;14)(p13;q32): a recurring abnormality in lymphocytic leukemia. A Pediatric Oncology Group study. Cancer Genet Cytogenet. 1992; (2): 121-4
- Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study. Clin Orthop Relat Res. 1991; (270): 8-14
- Changing pattern of pulmonary metastases with adjuvant chemotherapy in patients with osteosarcoma: results from the multiinstitutional osteosarcoma study. J Clin Oncol. 1991; (4): 600-5
- Consistent involvement of the bcr gene by 9;22 breakpoints in pediatric acute leukemias. Blood. 1991; (2): 324-30
- Hodgkin's disease. Treatment of the young child. Pediatr Clin North Am. 1991; (2): 457-73
- Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings. Pediatrics. 1991; (2): 166-70
- Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A Pediatric Oncology Group study. J Neurosurg. 1991; (6): 905-9
- Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood. 1991; (5): 1050-6
- The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias. Blood. 1991; (4): 687-93
- Down-regulated c-myb expression inhibits DNA synthesis of T-leukemia cells in most patients. Cancer Res. 1990; (22): 7371-5
- Intensive sequential chemotherapy for children with acute myelogenous leukemia. Haematol Blood Transfus. 1990: 193-7
- Near-triploid and near-tetraploid acute lymphoblastic leukemia of childhood. Blood. 1990; (3): 590-6
- Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study. Blood. 1990; (3): 489-94
- Results of treatment of childhood localized non-Hodgkin's lymphoma with combination chemotherapy with or without radiotherapy. N Engl J Med. 1990; (17): 1169-74
- Stage I-II pediatric Hodgkin's disease: long-term follow-up demonstrates equivalent survival rates following different management schemes. J Clin Oncol. 1990; (7): 1128-37
- The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood. 1990; (6): 1220-4
- Absence of Ig V region gene somatic hypermutation in advanced Burkitt's lymphoma. J Immunol. 1989; (2): 692-8
- Aggressive management of second primary tumors in survivors of hereditary retinoblastoma. Int J Radiat Oncol Biol Phys. 1989; (3): 499-505
- Cerebellar atrophy caused by high-dose cytosine arabinoside: CT and MR findings. AJR Am J Roentgenol. 1989; (2): 343-4
- Clinical investigations of children with Hodgkin's disease at Stanford University Medical Center. A preliminary overview using low-dose irradiation and alternating ABVD/MOPP chemotherapy. Cancer Treat Res. 1989: 307-15
- Cytotoxic T lymphocytes specific for self tumor immunoglobulin express T cell receptor delta chain. J Exp Med. 1989; (5): 1557-64
- Diffuse small noncleaved cell lymphoma in children, Burkitt's versus non-Burkitt's types. Results from the Pediatric Oncology Group and St. Jude Children's Research Hospital. Cancer. 1989; (1): 23-8
- Long-term growth of malignant thymocytes in vitro. Blood. 1989; (8): 2182-7
- Pediatric Hodgkin's disease: pulmonary, cardiac, and thyroid function following combined modality therapy. Int J Radiat Oncol Biol Phys. 1989; (3): 679-85
- Poor-risk non-lymphoblastic lymphoma of childhood: results of an intensive pilot study. Med Pediatr Oncol. 1989; (1): 29-38
- Small cell osteosarcoma. A clinicopathologic study of 27 cases. Cancer. 1989; (10): 2162-73
- Clinical and biologic characterization of T-cell neoplasias with rearrangements of chromosome 7 band q34. Blood. 1988; (2): 395-402
- Continuing rearrangement but absence of somatic hypermutation in immunoglobulin genes of human B cell precursor leukemia. J Exp Med. 1988; (1): 229-45
- Idiotype as a tumor-specific marker in childhood B cell acute lymphoblastic leukemia. Blood. 1988; (4): 1068-73
- Philadelphia chromosome-positive acute lymphoblastic leukemia cell lines without classical breakpoint cluster region rearrangement. Cancer Res. 1988; (10): 2876-9
- Treatment of osteosarcoma. Lancet. 1988; (8598): 1334
- Absence of cell surface LFA-1 as a mechanism of escape from immunosurveillance. Lancet. 1987; (8558): 533-6
- Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease. J Clin Oncol. 1987; (5): 742-9
- Establishment and characterization of a common acute lymphoblastic leukemia cell line with a deletion of chromosome 3 band q26. Cancer Res. 1987; (6): 1652-6
- Giant cell pneumonia caused by parainfluenza type 3 in a patient with acute myelomonocytic leukemia. Arch Pathol Lab Med. 1987; (6): 569-70
- Improved results of treatment of adult acute lymphoblastic leukemia. Blood. 1987; (4): 1242-8
- Postremission induction intensive sequential chemotherapy for children with AML--treatment results and prognostic factors. Haematol Blood Transfus. 1987: 88-92
- Prognostic factors in childhood acute myelogenous leukemia. J Clin Oncol. 1987; (7): 1026-32
- Quantitation and estimation of lymphocyte subsets in tissue sections. Comparison with flow cytometry. Am J Clin Pathol. 1987; (4): 470-7
- Weekly high-dose methotrexate and doxorubicin for osteosarcoma: the Dana-Farber Cancer Institute/the Children's Hospital--study III. J Clin Oncol. 1987; (8): 1178-84
- A unique antigen on mature B cells defined by a monoclonal antibody. J Immunol. 1986; (9): 3013-8
- Adjuvant therapy in the treatment of osteosarcoma. Important Adv Oncol. 1986: 193-207
- Chromosome 9 abnormalities in childhood T-cell leukemia. N Engl J Med. 1986; (3): 195-6
- Chromosome clues to acute leukemia in Down's syndrome. Cancer Genet Cytogenet. 1986; (2): 93-8
- Chronic infectious mononucleosis syndrome, pancytopenia, and polyclonal B-lymphoproliferation terminating in acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol. 1986; (1): 18-27
- Common mechanism of chromosome inversion in B- and T-cell tumors: relevance to lymphoid development. Science. 1986; (4773): 197-200
- Cytogenetic and immunophenotypic analysis of cell lines established from patients with T cell leukemia/lymphoma. Blood. 1986; (3): 650-6
- Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia. Blood. 1986; (2): 474-8
- Mediastinal nonlymphoblastic lymphomas in children: a clinicopathologic study. J Clin Oncol. 1986; (2): 154-9
- The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med. 1986; (25): 1600-6
- Abnormal helper:suppressor T-cell ratio in the staff of a pediatric hospital. N Engl J Med. 1985; (24): 1573-4
- Acute leukemias associated with the 4;11 chromosome translocation have rearranged immunoglobulin heavy chain genes. Blood. 1985; (1): 33-8
- Conservative management of testicular endodermal sinus tumor in childhood. J Urol. 1985; (6): 1011-4
- Discordance between surface and cytoplasmic expression of the Leu-4 (T3) antigen in thymocytes and in blast cells from childhood T lymphoblastic malignancies. J Clin Invest. 1985; (1): 248-53
- Immunologic selection of hemopoietic precursor cells utilizing antibody-mediated plate binding ("panning"). Blood. 1985; (1): 190-7
- Leukemia with Down's syndrome: translocation between chromosomes 1 and 19 in acute myelomonocytic leukemia following transient congenital myeloproliferative syndrome. Blood. 1985; (6): 1466-8
- Non-Hodgkin's lymphoma in children. Pediatr Clin North Am. 1985; (3): 699-720
- A unique human B lymphocyte antigen defined by a monoclonal antibody. Hybridoma. 1984; (4): 305-20
- Acute nonlymphocytic leukemia developing during the course of Ewing's sarcoma. Med Pediatr Oncol. 1984; (3): 194-200
- Immune thrombocytopenia associated with acute nonlymphocytic leukemia. J Pediatr. 1984; (5): 776-8
- Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines. Cancer Res. 1984; (12 Pt 1): 5657-60
- Pan-leukocyte monoclonal antibody L3B12. Characterization and application to research and diagnostic problems. Am J Clin Pathol. 1984; (2): 176-83
- Prognostic significance of complete surgical resection of pulmonary metastases in patients with osteogenic sarcoma: analysis of 32 patients. J Clin Oncol. 1984; (5): 425-31
- Thyroid dysfunction after radiotherapy in children with Hodgkin's disease. Cancer. 1984; (4): 878-83
- A single monoclonal antibody identifies T-cell lineage of childhood lymphoid malignancies. Blood. 1983; (4): 722-8
- Cranial nerve involvement in children with leukemia and lymphoma. J Clin Oncol. 1983; (9): 542-5
- Cutaneous lymphoblastic lymphoma with pre-B markers. Blood. 1983; (5): 838-41
- Identification and significance of cell markers in leukemia and lymphoma. Annu Rev Med. 1983: 117-31
- Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine. J Clin Oncol. 1983; (3): 208-16
- Fetal-like erythropoiesis during recovery from transient erythroblastopenia of childhood (TEC). Pediatr Res. 1981; (7): 1036-9
- High-dose methotrexate in osteogenic sarcoma adjuvant chemotherapy and limb salvage results. Cancer Treat Rep. 1981: 99-106
- High-dose methotrexate in osteogenic sarcoma. Natl Cancer Inst Monogr. 1981; (56): 201-6
- Non-Hodgkin's lymphoma in childhood. Clin Haematol. 1979; (3): 699-716
Help
Trial Administration